Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Excellent news! Out first official exposure to ASCO world

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Jan 25, 2023 9:14am

222 Views

Post# 35244720

RE:RE:Excellent news! Out first official exposure to ASCO world

That's what stuck out to me, previously they went to these symposiums and talked broadly about PDT or PDT as a way to treat NMIBC but now they are presenting TLT's results and analysis. For those wanting more exposure you got it.

ScienceFirst wrote: The poster will include interim clinical data and analysis collected through the enrollment and treatment of patients at all Canadian and US clinical study site by their respective principal investigators for Study II.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?